{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:14:42Z","timestamp":1761750882148,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jiph.2021.07.018","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T23:59:22Z","timestamp":1627689562000},"page":"1169-1173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of dosing strategies on plasma concentrations of tenofovir: Implications in HIV pre-exposure prophylaxis in China"],"prefix":"10.1016","volume":"14","author":[{"given":"Jingchuan","family":"Shang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoni","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan","family":"Alnajebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0123-9913","authenticated-orcid":false,"given":"Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2021.07.018_bib0005","series-title":"China AIDS Report","first-page":"1","author":"2017 China HIV\/AIDS Report","year":"2017"},{"issue":"7","key":"10.1016\/j.jiph.2021.07.018_bib0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","article-title":"Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study","volume":"11","author":"Zhang","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2021.07.018_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-151-4-200908180-00006","article-title":"Five-year outcomes of the china national free antiretroviral treatment program","volume":"151","author":"Zhang","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jiph.2021.07.018_bib0020","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/OLQ.0b013e3181d13d2b","article-title":"HIV and syphilis among men who have sex with men in China: the time to act is now","volume":"37","author":"Muessig","year":"2010","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jiph.2021.07.018_bib0025","unstructured":"Baeten JM, Donnell D, Mujugira A. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, July 17-20 2011. Rome. MOAX0106."},{"issue":"27","key":"10.1016\/j.jiph.2021.07.018_bib0030","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiph.2021.07.018_bib0035","series-title":"6th IAS Conference on HIV Pathogenesis, Treatment and Prevention","article-title":"Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study","author":"Thigpen","year":"2011"},{"issue":"9581","key":"10.1016\/j.jiph.2021.07.018_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(07)61053-8","article-title":"Pre-exposure prophylaxis for HIV infection: what if it works?","volume":"370","author":"Paxton","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jiph.2021.07.018_bib0045","doi-asserted-by":"crossref","first-page":"14ra4","DOI":"10.1126\/scitranslmed.3000391","article-title":"Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection","volume":"2","author":"Garcia-Lerma","year":"2010","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.jiph.2021.07.018_bib0050","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"Garcia-Lerma","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jiph.2021.07.018_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/COH.0000000000000213","article-title":"Nondaily preexposure prophylaxis for HIV prevention","volume":"11","author":"Anderson","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"10.1016\/j.jiph.2021.07.018_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/jiw077","article-title":"A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine","volume":"214","author":"Cottrell","year":"2016","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.jiph.2021.07.018_bib0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1177\/0091270008322908","article-title":"Population pharmacokinetics of tenofovir in AIDS patients","volume":"48","author":"Gagnieu","year":"2008","journal-title":"J Clin Pharmacol"},{"issue":"9787","key":"10.1016\/j.jiph.2021.07.018_bib0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(11)60878-7","article-title":"Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women","volume":"378","author":"Karim","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jiph.2021.07.018_bib0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11904-008-0027-z","article-title":"Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research","volume":"5","author":"Stirratt","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"10.1016\/j.jiph.2021.07.018_bib0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tips.2009.10.009","article-title":"Oral pre-exposure prophylaxis for HIV prevention","volume":"31","author":"Garcia-Lerma","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jiph.2021.07.018_bib0085","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.50.4.1304-1310.2006","article-title":"Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state","volume":"50","author":"Chittick","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2021.07.018_bib0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection","volume":"66","author":"Anderson","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jiph.2021.07.018_bib0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"issue":"112","key":"10.1016\/j.jiph.2021.07.018_bib0100","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","article-title":"Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission","volume":"3","author":"Patterson","year":"2011","journal-title":"Sci Transl Med"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412100215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187603412100215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:11:08Z","timestamp":1761750668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187603412100215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S187603412100215X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2021.07.018","relation":{},"ISSN":["1876-0341"],"issn-type":[{"type":"print","value":"1876-0341"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of dosing strategies on plasma concentrations of tenofovir: Implications in HIV pre-exposure prophylaxis in China","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2021.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}